Biodelivery Sci Intl (NASDAQ:BDSI) shares traded -1.61% down during most recent session to reach at the closing price of $4.88. The stock exchanged hands 808463 shares versus average trading capacity of 1.1 Million shares, yielding a market cap of $429.93 Million. Wall Street analysts covering the stock are projecting that the stock will reach $7.38 within the next 52-weeks. The mean target projections are based on 6 opinions.
Taking a broader look brokerage firms’ analysts on the street with an expectant view have Biodelivery Sci Intl (NASDAQ:BDSI) high price target of $9 and with a conservative view have low price target of $6.
“Initiates Coverage On” Biodelivery Sci Intl (NASDAQ:BDSI) in a research note issued to investors on 3/20/19 to Buy with price target of $7.
Additionally on 1/31/19 “Assumes” Biodelivery Sci Intl (NASDAQ:BDSI) to Buy and on 5/23/18 “Maintained” the stock to Buy at $3.5. Furthermore on 1/26/18 “Initiates Coverage On” the stock to Buy at $5.
On the other hand the company has Relative Strength Index (RSI 14) of 51.36 along with Average True Range (ATR 14) of 0.21, Consequently Biodelivery Sci Intl (NASDAQ:BDSI)’s weekly and monthly volatility is 4.60%, 4.51% respectively. The company’s beta value is at 0.37.
In terms of Buy, Sell or Hold recommendations, Biodelivery Sci Intl (NASDAQ:BDSI) has analysts’ mean recommendation of 1.6. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.
According to analysts Biodelivery Sci Intl (NASDAQ:BDSI)’s minimum EPS for the current quarter is at $-0.08 and can go high up to $-0.02. The consensus mean EPS for the current quarter is at $-0.05 derived from a total of 7 estimates from the analysts who have weighed in on projected earnings. However the company reported $-0.16 earnings per share for the same quarter during last year.
Previously Biodelivery Sci Intl (NASDAQ:BDSI) reported $-0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $-0.08 by $0.03. The company posted an earnings surprise of 37.5%.
Biodelivery Sci Intl (NASDAQ:BDSI)’s revenue estimates for the current quarter are $23.46 Million according to 7 number of analysts, for the current quarter the company has high revenue estimates of $24.77 Million in contradiction of low revenue estimates of $21.96 Million. For the current year the company’s revenue estimates are $97.02 Million compared to low analyst estimates of $92.14 Million and high estimates of $102.46 Million according to 7 number of analysts.
Currently Biodelivery Sci Intl (NASDAQ:BDSI)’s shares owned by insiders are 4%, whereas shares owned by institutional owners are 52.3%. However the six-month change in the insider ownership was recorded -38.45%, as well as three-month change in the institutional ownership was recorded 10.94%.
Biodelivery Sci Intl (NASDAQ:BDSI)’s trailing twelve month revenues are $64.1 Million, whereas its price to sales ratio for the same period is 6.71. Its book value per share for the most recent quarter is $0.39 while its price to book ratio for the same period is 12.51, as for as the company’s cash per share for the most recent quarter is $0.47, however its price to cash per share ratio for the same period is 10.41. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.